Parkinson Disease

February 6th 2025

Onapgo is the first and only subcutaneous apomorphine infusion device for the treatment of motor fluctuations in people with advanced Parkinson disease.

January 9th 2025

Buntanetap is an oral molecule designed to inhibit the production of multiple neurotoxic proteins and is under investigation for treatment of Alzheimer Disease, Parkinson’s Disease, and other neurodegenerative diseases.

February 27th 2023

The association between air pollution and Parkinson disease was found strongest in the Rocky Mountain region and the Mississippi-Ohio River Valley in a new study.

February 3rd 2015

This adult beverage may actually provide health benefits, specifically for Alzheimer, Parkinson, and other neurological conditions.